Sci Immunol 2021[Jun]; 6 (60): ä PMID34088747show ga
A new high-throughput screening technique detected autoantibodies in COVID-19 patients specific for many different immunomodulatory extracellular and cell surface proteins, several of which were associated with disease severity and clinical outcomes.